Evidence map›Paper›PMID 15837784›Full record

ArticleThe Journal of biological chemistry2005

Down-regulation of ATM protein sensitizes human prostate cancer cells to radiation-induced apoptosis.

Jean-Philip Truman, Nuri Gueven, Martin Lavin, Steven Leibel, Richard Kolesnick, Zvi Fuks, Adriana Haimovitz-Friedman

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Review
  3. Acid Sphingomyelinase-Ceramide Induced Vascular Injury Determines Colorectal Cancer Stem Cell Fate.Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology · 2022
    Article
  4. Article
  5. Autophagic Organelles in DNA Damage Response.Frontiers in cell and developmental biology · 2021
    Review
  6. Article
  7. Article
  8. Review
  9. The effect of radiation on the immune response to cancers.International journal of molecular sciences · 2014
    Review
  10. Honokiol as a Radiosensitizing Agent for Colorectal cancers.Current colorectal cancer reports · 2013
    Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jean-Philip TrumanDepartment of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.
Nuri Gueven
Martin Lavin
Steven Leibel
Richard Kolesnick
Zvi Fuks
Adriana Haimovitz-Friedman
Memorial Sloan Kettering Cancer Center · US

Funding

SPORE In Prostate CancerP50CA092629 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Yu Chen, MICHAEL J MORRIS · 2001 to 2026
$63.0M
NCI NIH HHS CA92629-01NCI NIH HHS P50 CA092629
6 · The paper itself

Abstract

Treatment with the protein kinase C activator 12-O-tetradecanoylphorbol 12-acetate (TPA) enables radiation-resistant LNCaP human prostate cancer cells to undergo radiation-induced apoptosis, mediated via activation of the enzyme ceramide synthase (CS) and de novo synthesis of the sphingolipid ceramide (Garzotto, M., Haimovitz-Friedman, A., Liao, W. C., White-Jones, M., Huryk, R., Heston, D. W. W., Cardon-Cardo, C., Kolesnick, R., and Fuks, Z. (1999) Cancer Res. 59, 5194-5201). Here, we show that TPA functions to decrease the cellular level of the ATM (ataxia telangiectasia mutated) protein, known to repress CS activation (Liao, W.-C., Haimovitz-Friedman, A., Persaud, R., McLoughlin, M., Ehleiter, D., Zhang, N., Gatei, M., Lavin, M., Kolesnick, R., and Fuks, Z. (1999) J. Biol. Chem. 274, 17908-17917). Gel shift analysis in LNCaP and CWR22-Rv1 cells demonstrated a significant reduction in DNA binding of the Sp1 transcription factor to the ATM promoter, and quantitative reverse transcription-PCR showed a 50% reduction of ATM mRNA between 8 and 16 h of TPA treatment, indicating that TPA inhibits ATM transcription. Furthermore, treatment of LNCaP, CWR22-Rv1, PC-3, and DU-145 human prostate cells with antisense-ATM oligonucleotides, which markedly reduced cellular ATM levels, significantly enhanced radiation-induced CS activation and apoptosis, leading to apoptosis at doses as a low as 1 gray. These data suggest that the CS pathway initiates a generic mode of radiation-induced apoptosis in human prostate cancer cells, regulated by a suppressive function of ATM, and that ATM might represent a potential target for pharmacologic inactivation with potential clinical applications in human prostate cancer.

Indexed as

ApoptosisDown-RegulationAtaxia Telangiectasia Mutated ProteinsBlotting, WesternCell CycleCell Cycle ProteinsCell DeathCell Line, TumorCell SeparationCeramidesDNA-Binding ProteinsDose-Response Relationship, DrugDose-Response Relationship, RadiationFlow CytometryHumansKineticsAtaxia Telangiectasia Mutated ProteinsATM protein, humanCell Cycle ProteinsCeramidesdihydroceramide desaturaseDNA-Binding ProteinsOligonucleotides, AntisenseOxidoreductasesProtein Serine-Threonine KinasesRadiation-Sensitizing AgentsRNA, MessengerSp1 Transcription FactorTumor Suppressor Proteins

Identifiers

PMID15837784
PMCPMC1855286
OpenAlexW1988935712

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.